Jon Snodgres - Chief Financial Officer at Repligen Corp

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
RGEN on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jon Snodgres since 12/22/2023

Holdings reported by Jon Snodgres for Repligen Corp

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 37.4K $5.5M $147.13 May 16, 2023 Direct

Transactions reported by Jon Snodgres for Repligen Corp

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.